Preparation of peptide microspheres using tumor antigen- derived peptides

Methods in Molecular Biology

Volumn 1139, Issue , 2014, Pages 443-452

  Bhatnagar, Santwana ^a   Naqvi, Raza Ali ^a   Ali, Riyasat ^a   Rao, D N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Microspheres; Peptides; PLGA; Vaccine delivery vehicles

Indexed keywords

MICROSPHERE; PEPTIDE; POLYGLACTIN; TUMOR ANTIGEN; DRUG CARRIER; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; CELL VIABILITY; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; EMULSION; IN VITRO STUDY; PARTICLE SIZE; PERIPHERAL BLOOD MONONUCLEAR CELL; SCANNING ELECTRON MICROSCOPY; SOLVENT EXTRACTION; ZETA POTENTIAL; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DELAYED RELEASE FORMULATION; DRUG EFFECT; HUMAN; IMMUNOLOGY; MONONUCLEAR CELL;

ANTIGENS, NEOPLASM; CELL SURVIVAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; HUMANS; LACTIC ACID; LEUKOCYTES, MONONUCLEAR; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; PEPTIDES; POLYGLYCOLIC ACID;

EID: 84909647508     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0345-0_34     Document Type: Article

References (16)

1. Owusu-Ababio G, Rogers JA (1996) Formulation and release kinetics of cephalexin monohydrate from biodegradable polymeric microspheres. J Microencapsul 13(2): 195-205.
2. Dinarvand R et al (2006) Preparation, characterization and in vitro drug release properties of polytrimethylene carbonate/polyadipic anhydride blend microspheres. J Appl Polym Sci 101(4): 2377-2383.
3. Shokri N et al (2011) Preparation and evaluation of poly (caprolactone fumarate) nanoparticles containing doxorubicin HC1. Daru 19(1): 12-22.
4. Yousefpour P et al (2011) Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab. Int J Nanomedicine 6: 1977-1990.
5. Dinarvand R et al (2011) Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomedicine 6: 877-895.
6. Edlund U, Albertsson AC (2002) Degradable polymer microspheres for controlled drug delivery. Adv Polymer Sci 157: 67-112.
7. Muthu MS (2009) Nanoparticles based on PLGA and its copolymer: an overview. Asian J Pharm 3: 266-273.
8. Par T (1994) Degradation of poly (D, L-lactic acid) microspheres: effect of molecular weight. J Control Release 30(2): 161-173.
9. Budhian A et al (2007) Haloperidol-loaded PLGA nanoparticles: systemic study of particle size and drug content. Int J Pharm 336: 367-375.
10. Benoit MA et al (1999) Preparation and characterization of protein-loaded poly (ε-caprolactone) microparticle for oral vaccine delivery. Int J Pharm 184: 73-84.
11. Cryan SA (2005) Carrier based strategies for targeting protein and peptide drugs to the lungs. AAPS J 7(1): E20-E41.
12. Jiang W et al (2005) Biodegradable poly (lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev 57: 391-410.
13. Khan AA et al (2008) Identifying B and T epitopes and studying humoral, mucosal and cellular immune response of V antigen of Y. pestis. Vaccine 26: 316-332.
14. Jayaprakash Babu US et al (2011) Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide comprising of defined epitopes of LcrV antigen of Yersinia pestis coupled to palmitate in mice. Vaccine 29: 9352-9360.
15. Desai MP et al (1996) Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 13: 1838-1845.
16. Diaz RV et al (1999) One month sustained release microspheres of 125-I-bovine calcitonin: in vitro-in vivo studies. J Control Release 59: 55-62.